Page last updated: 2024-12-07
nepitrin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 120742 |
| CHEMBL ID | 517682 |
| CHEBI ID | 191783 |
| MeSH ID | M0109564 |
Synonyms (44)
| Synonym |
|---|
| 569-90-4 |
| nepitrin |
| 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(beta-d-glucopyranosyloxy)-5-hydroxy-6-methoxy- |
| eupatolin 7-glucoside |
| 5,3,4-trihydroxy-6-methoxyflavonoid |
| 6-methoxyluteolin 7-glucoside |
| nepetin 7-glucoside |
| 3',4',5-trihydroxy-6-methoxy-7-(glucosyloxy)flavone |
| CHEMBL517682 |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one |
| s9zmj20nuo , |
| unii-s9zmj20nuo |
| nepetin-7-glucoside |
| AC-34360 |
| Q-100656 |
| nepetin-7-glucopyranoside |
| 6-methoxyluteolin 7-o-glucoside |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)chromen-4-one |
| flavone, 3',4',5,7-tetrahydroxy-6-methoxy-, 7-.beta.-d-glucopyranoside |
| 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-6-methoxy- |
| eupafolin 7-o-.beta.-glucoside |
| 5-hydroxy-6-methoxy-2-(3,4-dihydroxyphenyl)-7-(.beta.-d-glucopyranosyloxy)-4h-1-benzopyran-4-one |
| eupafolin 7-.beta.-glucoside |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)-4h-chromen-4-one |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-4-oxo-4h-chromen-7-yl .beta.-d-glucopyranoside |
| j16.151i , |
| nepetrin |
| nepetin 7-o-.beta.-d-glucoside |
| eupafolin 7-o-.beta.-d-glucopyranoside |
| nepetin 7-o-glucoside |
| nepetin 7-o-.beta.-d-glucopyranoside |
| 27923-79-1 |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h-chromen-4-one |
| eupafolin-7-glucoside |
| 6-methoxyluteolin-7-glucoside |
| AKOS037514751 |
| HY-N5010 |
| mfcd01662760 |
| DTXSID00972339 |
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-6-methoxy-4-oxo-4h-1-benzopyran-7-yl hexopyranoside |
| Q27289103 |
| CS-0032071 |
| MS-28870 |
| CHEBI:191783 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (2)
| Class | Description |
|---|---|
| flavonoids | Any organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them. |
| glycoside | A glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID378879 | Antioxidant activity in human HL60 cells assessed as reduction of cytochrome-c release | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Acylated flavonol glycosides from the flower of Inula britannica. |
| AID378878 | Antioxidant activity assessed as DPPH free radical scavenging activity | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Acylated flavonol glycosides from the flower of Inula britannica. |
| AID378880 | Antioxidant activity in human HL60 cells assessed as inhibition of TPA-induced free radical formation | 2000 | Journal of natural products, Jan, Volume: 63, Issue:1 | Acylated flavonol glycosides from the flower of Inula britannica. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 20.35
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.35) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||